Stilla Technologies Strengthens Executive Team with Appointment of Matthew Grow, PhD, to Vice President Global Marketing and Commercial Operations
Life Sciences Veteran to Lead Commercialization of Disruptive Digital PCR Technology for a Broad Range of Basic Research and Clinical Applications
BOSTON and PARIS, June 30, 2021, – Stilla Technologies, the company innovating the next generation of digital PCR solutions for life science research and clinical diagnostics, today announced the appointment of Matthew Grow, PhD, to Vice President of Global Marketing and Commercial Operations. Trained as a molecular biologist, Dr. Grow brings over 25 years of experience in biological research and commercial management to Stilla during a time of dynamic growth for the company and for digital PCR, which is transforming the fields of genomics and genetic analysis.
“We are thrilled to welcome Matt on board as Stilla looks to become a mainstay force across the global genomics research and genetic testing markets,” said Philippe Mourere, President and CEO, Stilla Technologies. “His solid track record of commercializing multiplex platforms and building core commercial teams will serve Stilla well as we enter our next phase of development.”
Read the full press release